As of June 2026 Dermapharm has a market cap of NZ$4.60 Billion. This makes Dermapharm the world's 4303th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.